TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18997143

Group type: EXPERIMENTAL
Intervention: African Americans not filling prescription medications
Number of subjects: 399

Group type: COMPARATOR
Intervention: White patients not filling prescription medications
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Perceived income inadequacy among African Americans
Number of subjects: 399

Group type: COMPARATOR
Intervention: Perceived income inadequacy among white patients
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Odds ratio for African Americans not filling prescriptions
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Odds ratio after adding perceived income inadequacy as a mediator
Number of subjects: 399
Study: 16380496

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3' UTR BPI polymorphism
Number of subjects: 0
Study: 12791815

Group type: EXPERIMENTAL
Intervention: Ultrafiltration using 10-kDa filters
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ultrafiltration compared with GFR method
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 61
Study: 10977022

Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management Profile (DSMP)
Number of subjects: 105
Study: 8866922

Group type: EXPERIMENTAL
Intervention: Methotrexate plus flucloxacillin (500 mg four times a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Methotrexate alone (5‐15 mg per week)
Number of subjects: 10
Study: 1612904

Group type: EXPERIMENTAL
Intervention: 5 x 10(6) IU rIFN‐beta per injection
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3 x 10(6) IU rIFN‐beta per injection
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intratumoral application of rIFN‐beta
Number of subjects: 10
Study: 6323783

Group type: EXPERIMENTAL
Intervention: Two-drug combination (ACNU . VCR, ADM . VCR)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Three-drug combination (ACNU . CPA . VCR, ACNU . ADM . VCR)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Performance Status (PS) 0-1 group
Number of subjects: 47
Study: 30764860

Group type: EXPERIMENTAL
Intervention: 6-week pulmonary rehabilitation programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 27233251

Group type: EXPERIMENTAL
Intervention: Aminophylline (75 mg administered intravenously 90 seconds after 99mTc-tetrofosmin injection)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Placebo (administered intravenously 90 seconds after 99mTc-tetrofosmin injection)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Aminophylline (75 mg)
Number of subjects: 548
Study: 25890283

Group type: EXPERIMENTAL
Intervention: Game-based appointment system with educational content
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational content only
Number of subjects: 0
Study: 24129130

Group type: EXPERIMENTAL
Intervention: Initial infliximab treatment
Number of subjects: 229

Group type: COMPARATOR
Intervention: Delayed infliximab treatment (in arms 1-3)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Post-discontinuation of infliximab
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Restarting infliximab
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Median time without infliximab treatment
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Independent predictors of infliximab restart
Number of subjects: 229
Study: 21104431

Group type: EXPERIMENTAL
Intervention: FRAME intervention (couples' group)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: FRAME intervention (women-only group)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: FRAME intervention (men-only group)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: FRAME intervention
Number of subjects: 173

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 173
Study: 19632961

Group type: EXPERIMENTAL
Intervention: Task-oriented plus functional electrical stimulation (FES) training
Number of subjects: 46

Group type: COMPARATOR
Intervention: Task-oriented training (control)
Number of subjects: 46
Study: 17283346

Group type: EXPERIMENTAL
Intervention: Ambulatory CPAP titration
Number of subjects: 68

Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 68
Study: 15090768

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 229

Group type: COMPARATOR
Intervention: No Nevirapine (Control)
Number of subjects: 229

Group type: COMPARATOR
Intervention: No Hydroxyurea (Control)
Number of subjects: 229
Study: 11445632

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (100 mg weekly intramuscular injections)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (saline injections)
Number of subjects: 25
Study: 9763809

Group type: EXPERIMENTAL
Intervention: Epidural clonidine 150 micrograms in NS 10 ml (group C, n 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: NS 10 ml as placebo (group P, n 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural clonidine 150 micrograms
Number of subjects: 40
Study: 8143016

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 39
Study: 3064254

Group type: EXPERIMENTAL
Intervention: Veralipride (1 tablet per day for 20 days)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Veralipride
Number of subjects: 144
Study: 31965445

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 526

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study: 31536430

Group type: EXPERIMENTAL
Intervention: Group 1 (vibration + noise)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Group 2 (vibration only)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Group 3 (no exposure)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Group 1 vs Group 3
Number of subjects: 138

Group type: COMPARATOR
Intervention: Group 2 vs Group 3
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Group 1 vs Group 2
Number of subjects: 138
Study: 28424510

Group type: EXPERIMENTAL
Intervention: Slow breathing training against an inspiratory resistance of 18 cmH2O for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal breathing)
Number of subjects: 20
Study: 25361436

Group type: EXPERIMENTAL
Intervention: Atazanavir/Cobicistat fixed-dose combination (300/150 mg)
Number of subjects: 64
Study: 24090379

Group type: EXPERIMENTAL
Intervention: Combined treatment with simvastatin (40 mg/day) and ezetimibe (20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Monotherapy with simvastatin (80 mg/day)
Number of subjects: 100
Study: 21355151

Group type: EXPERIMENTAL
Intervention: Du-moxibustion combined with western medicine (herb-partitioned spread moxibustion on the Governor Vessel between Dazhui (GV 14) and Yaoshu (GV 2))
Number of subjects: 210

Group type: COMPARATOR
Intervention: Simple western medicine
Number of subjects: 210
Study: 18469241

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Lifestyle group
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Metformin group
Number of subjects: 1106
Study: 17063293

Group type: EXPERIMENTAL
Intervention: Laparoscopy and open exploration (including scar revision and neurectomy)
Number of subjects: 24
Study: 14563190

Group type: EXPERIMENTAL
Intervention: Diuretics plus albumin (n = 63)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Albumin treatment (25 g/week)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Albumin treatment
Number of subjects: 126
Study: 10852611

Group type: EXPERIMENTAL
Intervention: 2.4 mg/day of folic acid (FA), 50.0 mg/day of vitamin B6, 0.4 mg/day of vitamin B12
Number of subjects: 49

Group type: COMPARATOR
Intervention: 15 mg/day of folic acid (FA) or 17 mg/day of L-5-methyltetrahydrofolate, 50.0 mg/day of vitamin B6, 1.0 mg/day of vitamin B12
Number of subjects: 49
Study: 9583629

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) - subjects could select one product of their choice or were randomly assigned a product during the study weeks.
Number of subjects: 143
Study: 8408988

Group type: EXPERIMENTAL
Intervention: Synthesis teaching
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Parent training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (problem discussions)
Number of subjects: 29
Study: 3776776

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30182639

Group type: EXPERIMENTAL
Intervention: NSPT plus anti-oxidant gel formula (propolis)
Number of subjects: 40

Group type: COMPARATOR
Intervention: NSPT plus chlorhexidine gel formula
Number of subjects: 40
Study: 26496015

Group type: EXPERIMENTAL
Intervention: Asenapine 5 mg bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asenapine 10 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24748465

Group type: EXPERIMENTAL
Intervention: RT + dCIT
Number of subjects: 48

Group type: COMPARATOR
Intervention: RT
Number of subjects: 48

Group type: COMPARATOR
Intervention: CR
Number of subjects: 48
Study: 22264742

Group type: EXPERIMENTAL
Intervention: Alcohol hand gel application every 60 minutes (q 60)
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Alcohol hand gel application every 120 minutes (q 120)
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Alcohol hand gel application only before lunch (q lunch)
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Comparison between q 60 and q 120
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Comparison between q 60 and q lunch
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Comparison between q 120 and q lunch
Number of subjects: 1437
Study: 21035620

Group type: EXPERIMENTAL
Intervention: Specific processing condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: General processing condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control, no-processing condition
Number of subjects: 0
Study: 18609155

Group type: EXPERIMENTAL
Intervention: Gastric electrical stimulation (GES)
Number of subjects: 7
Study: 16104443

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12461065

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel (longer treatment, four days)
Number of subjects: 0
Study: 10071289

Group type: EXPERIMENTAL
Intervention: liarozole
Number of subjects: 191

Group type: COMPARATOR
Intervention: prednisone
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Bone Scan Index (BSI)
Number of subjects: 191
Study: 7572898

Group type: EXPERIMENTAL
Intervention: 2.1 mm tube
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 3.8 mm tube
Number of subjects: 8

Group type: COMPARATOR
Intervention: 2.1 mm tube together with no tube
Number of subjects: 8
Study: 2278869

Group type: EXPERIMENTAL
Intervention: Anistreplase
Number of subjects: 84

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 84
Study: 37142

Group type: EXPERIMENTAL
Intervention: Prifinium bromide (90 mg daily before meals)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30610424

Group type: EXPERIMENTAL
Intervention: Bevacizumab + Macular Grid Photocoagulation (BEV + GRID)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 32
Study: 27838572

Group type: EXPERIMENTAL
Intervention: Exposure and Response Prevention (EX/RP) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 100
Study: 25809519

Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) transfusion (12 mL kg(‐1))
Number of subjects: 38
Study: 23203904

Group type: EXPERIMENTAL
Intervention: Nintendo-Wii® Bowling (60 min/twice a week for 6 weeks)
Number of subjects: 27
Study: 21389739

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone injection (IV group)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sub-Tenon (ST) posterior triamcinolone injection (ST group)
Number of subjects: 14
Study: 19571080

Group type: EXPERIMENTAL
Intervention: All-polyethylene tibial component
Number of subjects: 510

Group type: COMPARATOR
Intervention: Metal-backed tibial component
Number of subjects: 510
Study: 18257350

Group type: EXPERIMENTAL
Intervention: Diaformin combined with acupuncture at Baihui (GV 20) and Fengfu (GV 16)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diaformin (control group)
Number of subjects: 100
Study: 15151523

Group type: EXPERIMENTAL
Intervention: Fosfluconazole (1000 mg intravenous bolus injection)
Number of subjects: 0
Study: 14504947

Group type: EXPERIMENTAL
Intervention: Synchronous push strategy at 40 push min(‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Push frequency 40
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Push frequency 40 with synchronous strategy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Push frequency 70
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall RPE
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Local RPE
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Central RPE
Number of subjects: 12
Study: 10204194

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 7548798

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 19
Study: 2265258

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20-25% of energy as fat)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No dietary advice (Control group)
Number of subjects: 240
Study: 7467565

Group type: EXPERIMENTAL
Intervention: CAA therapy (chlorambucil, warfarin, dipyridamol, and prednisone)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: CP therapy (imuran and prednisone)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 110
Study: 31748227

Group type: EXPERIMENTAL
Intervention: rAd5 Gag/Pol and EnvA/B/C (3:1:1:1 mixture)
Number of subjects: 50

Group type: COMPARATOR
Intervention: rAd5 Gag/Pol
Number of subjects: 50
Study: 27612978

Group type: EXPERIMENTAL
Intervention: ECD intervention (early child development intervention)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: ECD intervention
Number of subjects: 534

Group type: COMPARATOR
Intervention: IHIP intervention (integrated household intervention package)
Number of subjects: 534
Study: 25823689

Group type: EXPERIMENTAL
Intervention: Supervised moderate-intensity running thrice a week for 10 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no exercise prescribed)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Supervised moderate-intensity running
Number of subjects: 30
Study: 24630934

Group type: EXPERIMENTAL
Intervention: Parental role modeling of fruits at dinner
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Parental role modeling of vegetables at snack
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Parental role modeling of salad at dinner
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Parental role modeling of fruit at snack
Number of subjects: 160
Study: 22999755

Group type: EXPERIMENTAL
Intervention: Percutaneous biliary balloon dilation (PBBD)
Number of subjects: 89
Study: 19443354

Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg b.d. for four weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 45
Study: 17900941

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (P‐Max Newtron)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Bur treatment
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (P‐Max Newtron) in molars
Number of subjects: 290

Group type: COMPARATOR
Intervention: Bur treatment in molars
Number of subjects: 290
Study: 14980290

Group type: EXPERIMENTAL
Intervention: Prenatal corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postnatal corticosteroids (early use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postnatal corticosteroids
Number of subjects: 0
Study: 12200104

Group type: EXPERIMENTAL
Intervention: Minimal-contact smoking cessation intervention (stop-smoking advice by cardiologist, brief counseling by nurse, provision of self-help materials, aftercare by cardiologist)
Number of subjects: 789

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 789
Study: 9685101

Group type: EXPERIMENTAL
Intervention: Count'R‐Force Tennis Elbow Brace
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Body Glove Airprene Elbow Support
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo brace (modified DePuy Levy Clinic Patella Strap)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No brace
Number of subjects: 50
Study: 7540796

Group type: EXPERIMENTAL
Intervention: Transurethral needle ablation (TUNA)
Number of subjects: 50
Study: 30689222

Group type: EXPERIMENTAL
Intervention: T3 infusion for eight hours
Number of subjects: 37

Group type: COMPARATOR
Intervention: T4 infusion for eight hours
Number of subjects: 37
Study: 28488462

Group type: EXPERIMENTAL
Intervention: Performance dentistry including occlusal equilibration (Group D)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham treatment (Group S)
Number of subjects: 38
Study: 25678302

Group type: EXPERIMENTAL
Intervention: Individuals with mild-moderate hip osteoarthritis (n=36)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Individuals without radiographic hip osteoarthritis (n=30)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 24394693

Group type: EXPERIMENTAL
Intervention: Partial coherence
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Directed transfer function
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Generalized partial directed coherence
Number of subjects: 72
Study: 21392851

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.2 mg/dL)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 38
Study: 20031836

Group type: EXPERIMENTAL
Intervention: Coronary revascularization (surgery or angioplasty)
Number of subjects: 113
Study: 17101640

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-45 mg/d)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Glimepiride (1-4 mg/d)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 462

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 462
Study: 16281663

Group type: EXPERIMENTAL
Intervention: Self-management programme (127 patients)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual care (121 patients)
Number of subjects: 248
Study: 11759474

Group type: EXPERIMENTAL
Intervention: Aprotinin (Antilysin Spofa) 2.10(6) KIU administered preoperatively and during the first hour of surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 42
Study: 9416856

Group type: EXPERIMENTAL
Intervention: Intravenous pulse cyclophosphamide (CYC) with prednisone (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral cyclophosphamide (CYC) with prednisone (group B)
Number of subjects: 50
Study: 8487657

Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemia (287 pmol/min/m2) in obese men
Number of subjects: 17

Group type: COMPARATOR
Intervention: Euglycemic hyperinsulinemia in non-obese men
Number of subjects: 17

Group type: COMPARATOR
Intervention: Euglycemic hyperinsulinemia in obese men
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rapid onset and cessation of hyperinsulinemia
Number of subjects: 17
Study: 3320787

Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 31531707

Group type: EXPERIMENTAL
Intervention: MILK MINERALS + PROTEIN
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PROTEIN
Number of subjects: 32

Group type: COMPARATOR
Intervention: MILK MINERALS
Number of subjects: 32

Group type: COMPARATOR
Intervention: CALCITR
Number of subjects: 32
Study: 29486367

Group type: EXPERIMENTAL
Intervention: Single dose of 150,000 IU vitamin D3
Number of subjects: 40

Group type: COMPARATOR
Intervention: Daily dose of 5000 IU vitamin D3
Number of subjects: 40
Study: 28069076

Group type: EXPERIMENTAL
Intervention: 55-g rye porridge
Number of subjects: 21

Group type: COMPARATOR
Intervention: Wheat bread (control)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Breath hydrogen
Number of subjects: 21
Study: 25239343

Group type: EXPERIMENTAL
Intervention: Surgisis Gold
Number of subjects: 402

Group type: COMPARATOR
Intervention: Suture closure alone
Number of subjects: 402
Study: 22024170

Group type: EXPERIMENTAL
Intervention: Plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 186
Study: 20415695

Group type: EXPERIMENTAL
Intervention: Portion control tool
Number of subjects: 130
Study: 18979160

Group type: EXPERIMENTAL
Intervention: Single dose of 300,000 IU cholecalciferol
Number of subjects: 28

Group type: COMPARATOR
Intervention: 800 IU daily cholecalciferol
Number of subjects: 28
Study: 15959426

Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate 200 mg and Vitamin E 400 IU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12773957

Group type: EXPERIMENTAL
Intervention: Oral ethinyl oestradiol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta oestradiol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral ethinyl oestradiol, conjugated equine oestrogen, oestradiol valerate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral oestrogen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Transdermal oestrogen
Number of subjects: 18
Study: 10338065

Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol
Number of subjects: 251

Group type: COMPARATOR
Intervention: 25 microg misoprostol
Number of subjects: 251